Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Marco Del Chiaro

Concepts (599)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
179
2026
919
33.670
 Why?
Pancreatectomy
81
2026
285
19.060
 Why?
Carcinoma, Pancreatic Ductal
72
2026
291
17.830
 Why?
Adenocarcinoma
33
2026
928
6.990
 Why?
Pancreaticoduodenectomy
35
2026
135
6.950
 Why?
Neoadjuvant Therapy
32
2026
462
6.710
 Why?
Adenocarcinoma, Mucinous
18
2025
76
5.270
 Why?
Pancreas
41
2026
341
4.220
 Why?
Mesenteric Veins
9
2025
23
3.980
 Why?
Portal Vein
13
2025
114
3.090
 Why?
Carcinoma, Papillary
11
2025
79
2.980
 Why?
Pancreatic Cyst
12
2025
50
2.820
 Why?
Antineoplastic Combined Chemotherapy Protocols
19
2026
1953
2.630
 Why?
Ampulla of Vater
8
2026
39
2.230
 Why?
Common Bile Duct Neoplasms
7
2026
27
2.200
 Why?
Pancreatic Fistula
11
2023
35
2.120
 Why?
Retrospective Studies
98
2026
17066
2.000
 Why?
CA-19-9 Antigen
5
2026
31
1.890
 Why?
Humans
258
2026
144759
1.880
 Why?
Aged
98
2026
25913
1.880
 Why?
Survival Rate
26
2026
2089
1.800
 Why?
Pancreatic Ducts
10
2022
81
1.750
 Why?
Prognosis
33
2026
4282
1.660
 Why?
Postoperative Complications
33
2026
2919
1.620
 Why?
Middle Aged
106
2026
35875
1.610
 Why?
Neoplasm Recurrence, Local
8
2026
1137
1.560
 Why?
Exocrine Pancreatic Insufficiency
5
2019
24
1.520
 Why?
Mesenteric Artery, Superior
5
2026
28
1.470
 Why?
Chemotherapy, Adjuvant
17
2026
421
1.450
 Why?
Vascular Surgical Procedures
5
2025
339
1.400
 Why?
Gastrointestinal Neoplasms
2
2023
70
1.360
 Why?
Early Detection of Cancer
6
2021
463
1.350
 Why?
Aged, 80 and over
46
2025
8265
1.330
 Why?
Male
122
2026
72315
1.290
 Why?
Pancreas Transplantation
24
2010
69
1.250
 Why?
Female
119
2026
78271
1.180
 Why?
Pancreatitis, Chronic
6
2020
63
1.080
 Why?
Treatment Outcome
41
2026
11679
1.060
 Why?
Neoplasms, Cystic, Mucinous, and Serous
4
2025
28
1.040
 Why?
Neoplasm Staging
15
2025
1462
1.020
 Why?
Databases, Factual
4
2025
1486
1.000
 Why?
Adult
77
2026
40449
0.960
 Why?
Quality of Life
8
2025
3185
0.950
 Why?
Anastomotic Leak
2
2025
44
0.950
 Why?
Islets of Langerhans
5
2020
833
0.940
 Why?
Chyle
1
2025
4
0.940
 Why?
Carcinoma, Neuroendocrine
2
2023
35
0.930
 Why?
Follow-Up Studies
24
2025
5408
0.930
 Why?
Endosonography
5
2021
157
0.920
 Why?
Biomarkers, Tumor
14
2026
1313
0.890
 Why?
Frozen Sections
1
2025
24
0.890
 Why?
Cystadenocarcinoma, Mucinous
3
2026
12
0.890
 Why?
Neoplasm Invasiveness
9
2025
508
0.880
 Why?
Nomograms
3
2022
59
0.870
 Why?
Precancerous Conditions
3
2015
166
0.870
 Why?
Liver Neoplasms
4
2024
780
0.840
 Why?
Hepatoblastoma
1
2024
52
0.820
 Why?
Duodenal Neoplasms
3
2023
26
0.810
 Why?
Thrombelastography
2
2024
178
0.790
 Why?
Minimally Invasive Surgical Procedures
3
2020
192
0.720
 Why?
Fluorouracil
11
2025
235
0.710
 Why?
Leucovorin
8
2025
101
0.690
 Why?
Surgical Stapling
1
2021
16
0.670
 Why?
Absorbable Implants
1
2021
37
0.670
 Why?
Risk Assessment
11
2025
3671
0.660
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2022
221
0.660
 Why?
Organ Transplantation
2
2023
247
0.650
 Why?
Neoplasms, Second Primary
2
2019
100
0.640
 Why?
Sweden
6
2025
111
0.630
 Why?
Vascular Neoplasms
1
2020
18
0.620
 Why?
Neoplasms, Multiple Primary
3
2015
58
0.620
 Why?
Arteries
2
2019
259
0.620
 Why?
Liver Transplantation
4
2024
823
0.610
 Why?
Adenocarcinoma, Papillary
2
2017
11
0.600
 Why?
Pancreatitis
5
2022
145
0.600
 Why?
Deoxycytidine
9
2025
221
0.600
 Why?
Endocrine System Diseases
1
2019
35
0.600
 Why?
Neuroendocrine Tumors
4
2023
112
0.570
 Why?
Practice Guidelines as Topic
3
2021
1560
0.560
 Why?
Risk Factors
20
2026
10779
0.540
 Why?
Neoplasm Metastasis
2
2025
688
0.540
 Why?
Incidence
10
2026
2879
0.530
 Why?
Cohort Studies
12
2024
5960
0.530
 Why?
Evidence-Based Medicine
5
2024
732
0.520
 Why?
Europe
8
2021
412
0.510
 Why?
Patient Compliance
1
2021
588
0.510
 Why?
Living Donors
3
2016
280
0.500
 Why?
Metabolomics
2
2019
727
0.500
 Why?
Kidney Transplantation
17
2016
704
0.500
 Why?
Patient Selection
9
2024
719
0.490
 Why?
Hepatic Artery
4
2020
53
0.490
 Why?
Celiac Artery
4
2020
20
0.480
 Why?
Hepatitis B virus
1
2016
33
0.470
 Why?
Watchful Waiting
1
2016
89
0.470
 Why?
Pancreaticojejunostomy
3
2022
9
0.470
 Why?
Prospective Studies
16
2026
7990
0.470
 Why?
Disease Progression
6
2025
2847
0.460
 Why?
Hypothermia, Induced
1
2016
96
0.450
 Why?
Practice Patterns, Physicians'
4
2025
1356
0.440
 Why?
Organ Sparing Treatments
1
2015
38
0.430
 Why?
Pancreatic Diseases
3
2020
66
0.430
 Why?
Survival Analysis
12
2024
1382
0.430
 Why?
Postoperative Care
3
2026
288
0.430
 Why?
Laparoscopy
4
2025
475
0.420
 Why?
Adenoma
3
2025
218
0.420
 Why?
Antineoplastic Agents
6
2021
2194
0.400
 Why?
Radiotherapy, Adjuvant
2
2024
222
0.390
 Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2019
219
0.390
 Why?
Clinical Trials as Topic
1
2018
1053
0.390
 Why?
Japan
5
2025
143
0.390
 Why?
Cystadenocarcinoma
1
2013
4
0.390
 Why?
Cystadenoma
1
2013
5
0.390
 Why?
Combined Modality Therapy
5
2024
1266
0.390
 Why?
Robotics
1
2014
87
0.380
 Why?
Propensity Score
4
2026
367
0.380
 Why?
Italy
11
2013
113
0.370
 Why?
Cystadenoma, Serous
3
2020
18
0.370
 Why?
Stomach Neoplasms
2
2024
126
0.370
 Why?
Carcinoma, Hepatocellular
1
2016
370
0.360
 Why?
Autoimmune Diseases
3
2021
463
0.360
 Why?
Diabetes Mellitus
3
2019
1098
0.360
 Why?
Tomography, X-Ray Computed
10
2021
2730
0.360
 Why?
Diagnosis, Differential
8
2022
1489
0.350
 Why?
Dilatation, Pathologic
3
2020
62
0.350
 Why?
Peritoneal Neoplasms
2
2024
103
0.350
 Why?
Palliative Care
3
2019
1002
0.340
 Why?
Lymphatic Metastasis
4
2026
333
0.340
 Why?
Cystadenoma, Mucinous
2
2026
11
0.340
 Why?
Predictive Value of Tests
7
2025
2115
0.330
 Why?
Risk
5
2022
911
0.330
 Why?
Gastroenterology
2
2023
189
0.330
 Why?
Gamma Rays
2
2021
56
0.330
 Why?
Adolescent
17
2026
22428
0.320
 Why?
Age Factors
7
2025
3333
0.320
 Why?
Portal System
6
2020
12
0.310
 Why?
Neoplastic Syndromes, Hereditary
1
2010
45
0.310
 Why?
Chemoradiotherapy
2
2022
237
0.310
 Why?
Young Adult
13
2026
14105
0.310
 Why?
Microbiota
3
2025
781
0.300
 Why?
Neoplasm Grading
4
2020
307
0.300
 Why?
Magnetic Resonance Imaging
8
2021
3863
0.300
 Why?
Tissue Donors
14
2005
424
0.300
 Why?
Decision Making
1
2016
975
0.290
 Why?
Kidney
2
2016
1495
0.290
 Why?
Benchmarking
2
2020
188
0.280
 Why?
Population Surveillance
2
2019
485
0.280
 Why?
Tumor Burden
2
2022
319
0.270
 Why?
Graft Survival
12
2005
526
0.260
 Why?
Software
2
2017
690
0.260
 Why?
Mass Screening
2
2019
1347
0.260
 Why?
Margins of Excision
2
2025
51
0.260
 Why?
Islets of Langerhans Transplantation
3
2020
67
0.250
 Why?
Genetic Predisposition to Disease
6
2019
2363
0.250
 Why?
Internationality
4
2020
156
0.250
 Why?
Family Health
1
2007
191
0.250
 Why?
Cytoreduction Surgical Procedures
2
2024
67
0.240
 Why?
Disease-Free Survival
5
2023
769
0.240
 Why?
Drainage
10
2022
185
0.240
 Why?
Pedigree
3
2014
514
0.240
 Why?
Intention to Treat Analysis
1
2026
80
0.240
 Why?
Multidetector Computed Tomography
2
2016
40
0.240
 Why?
Lymphocytes, Tumor-Infiltrating
2
2018
154
0.240
 Why?
Prevalence
4
2025
2834
0.230
 Why?
Immunohistochemistry
5
2019
1716
0.230
 Why?
Observer Variation
2
2024
355
0.230
 Why?
Pregnancy Complications, Neoplastic
1
2026
63
0.230
 Why?
Cyst Fluid
2
2022
20
0.230
 Why?
Length of Stay
5
2021
1337
0.220
 Why?
Pilot Projects
6
2026
1886
0.220
 Why?
Postoperative Hemorrhage
1
2026
104
0.220
 Why?
Diarrhea
1
2026
192
0.220
 Why?
Cholangiocarcinoma
2
2024
105
0.220
 Why?
Symptom Assessment
1
2026
137
0.220
 Why?
Mucosal-Associated Invariant T Cells
1
2025
37
0.220
 Why?
Pylorus
1
2024
17
0.220
 Why?
Proportional Hazards Models
4
2023
1325
0.210
 Why?
Chemoradiotherapy, Adjuvant
3
2019
44
0.210
 Why?
Gallbladder Neoplasms
1
2024
20
0.210
 Why?
Spheroids, Cellular
1
2025
73
0.210
 Why?
Cell Transformation, Neoplastic
1
2026
339
0.200
 Why?
Time Factors
10
2021
7173
0.200
 Why?
Perioperative Care
2
2024
231
0.200
 Why?
Lymph Node Excision
1
2024
173
0.200
 Why?
Metastasectomy
1
2023
19
0.200
 Why?
Incidental Findings
2
2021
80
0.190
 Why?
Hyperemia
1
2023
49
0.190
 Why?
Child, Preschool
6
2026
11787
0.190
 Why?
Hospital Mortality
4
2020
1030
0.190
 Why?
Bile Duct Neoplasms
1
2024
127
0.190
 Why?
Venous Thrombosis
1
2025
194
0.190
 Why?
Surgical Oncology
1
2022
30
0.190
 Why?
Reoperation
7
2018
630
0.180
 Why?
Hyperamylasemia
1
2022
3
0.180
 Why?
STAT3 Transcription Factor
2
2022
207
0.180
 Why?
Sensitivity and Specificity
3
2026
1985
0.180
 Why?
Pancreatitis, Acute Necrotizing
1
2022
14
0.180
 Why?
Forecasting
1
2023
391
0.180
 Why?
Carcinoma, Acinar Cell
1
2021
4
0.180
 Why?
Colonic Neoplasms
1
2024
259
0.180
 Why?
Plastics
1
2022
47
0.180
 Why?
Pathology, Clinical
1
2021
29
0.170
 Why?
Biliary Tract Surgical Procedures
1
2021
28
0.170
 Why?
Angiotensin Receptor Antagonists
1
2022
114
0.170
 Why?
Datasets as Topic
1
2021
122
0.170
 Why?
Cysts
1
2022
111
0.170
 Why?
Multicenter Studies as Topic
1
2023
405
0.170
 Why?
ADAM10 Protein
1
2021
29
0.170
 Why?
Surgical Mesh
1
2021
50
0.170
 Why?
Fusobacterium nucleatum
1
2020
4
0.160
 Why?
Fusobacterium Infections
1
2020
7
0.160
 Why?
Bacteria
2
2025
889
0.160
 Why?
Netherlands
3
2025
82
0.160
 Why?
Amyloid Precursor Protein Secretases
1
2021
77
0.160
 Why?
United States
5
2025
15966
0.160
 Why?
Digestive System Surgical Procedures
1
2021
109
0.160
 Why?
Albumins
3
2025
118
0.160
 Why?
Surgeons
1
2025
339
0.160
 Why?
Body Composition
1
2024
706
0.160
 Why?
Microdissection
2
2011
15
0.160
 Why?
Oligonucleotides, Antisense
1
2020
116
0.160
 Why?
Blood
1
2020
109
0.160
 Why?
Antimetabolites, Antineoplastic
2
2010
105
0.160
 Why?
Quality Improvement
2
2026
1289
0.160
 Why?
Antibodies, Bacterial
1
2020
148
0.150
 Why?
Myeloid-Derived Suppressor Cells
1
2020
72
0.150
 Why?
Cyclosporine
4
2005
265
0.150
 Why?
Paclitaxel
3
2025
255
0.150
 Why?
Comorbidity
2
2022
1658
0.150
 Why?
Radiation Injuries
1
2021
151
0.150
 Why?
Conservative Treatment
1
2020
44
0.150
 Why?
Lasers
2
2011
132
0.150
 Why?
Dilatation
1
2019
72
0.150
 Why?
Cystadenocarcinoma, Serous
1
2020
84
0.150
 Why?
Biliary Tract Diseases
1
2019
33
0.150
 Why?
Epithelial-Mesenchymal Transition
1
2021
219
0.140
 Why?
Laparotomy
2
2016
112
0.140
 Why?
Bacterial Infections
1
2021
246
0.140
 Why?
Bile Ducts
1
2019
67
0.140
 Why?
Elective Surgical Procedures
1
2020
201
0.140
 Why?
Organ Culture Techniques
1
2019
154
0.140
 Why?
Mouth
1
2019
88
0.140
 Why?
Immunosuppressive Agents
6
2005
846
0.140
 Why?
Saliva
1
2020
249
0.140
 Why?
Nutritional Support
1
2018
39
0.140
 Why?
Fibrosis
1
2021
548
0.140
 Why?
Gene Expression Regulation, Neoplastic
4
2019
1455
0.140
 Why?
Iopamidol
2
2016
12
0.140
 Why?
Referral and Consultation
1
2024
851
0.130
 Why?
Recombinant Fusion Proteins
4
2005
675
0.130
 Why?
Patient Care Team
3
2020
689
0.130
 Why?
DNA Damage
1
2021
430
0.130
 Why?
Jejunum
2
2016
35
0.130
 Why?
Carcinoma
1
2019
228
0.130
 Why?
Preoperative Care
2
2026
379
0.130
 Why?
Insulin
8
2013
2507
0.130
 Why?
Societies, Medical
2
2020
887
0.130
 Why?
DNA, Bacterial
1
2019
342
0.130
 Why?
Logistic Models
2
2020
2117
0.130
 Why?
Kaplan-Meier Estimate
2
2016
965
0.130
 Why?
Surveys and Questionnaires
5
2025
6048
0.130
 Why?
Patient Acceptance of Health Care
1
2024
885
0.130
 Why?
Malnutrition
1
2018
86
0.130
 Why?
Analgesics, Opioid
1
2025
1143
0.120
 Why?
Radiosurgery
1
2020
400
0.120
 Why?
Hepatic Duct, Common
1
2016
5
0.120
 Why?
Biliary Tract Neoplasms
1
2016
30
0.120
 Why?
Jaundice, Obstructive
1
2016
3
0.120
 Why?
Cross-Sectional Studies
3
2024
5868
0.120
 Why?
Epitopes
1
2018
485
0.120
 Why?
Cholangiopancreatography, Magnetic Resonance
1
2016
24
0.120
 Why?
Triiodobenzoic Acids
1
2016
6
0.120
 Why?
Organ Preservation Solutions
3
2005
47
0.120
 Why?
Hyperglycemia
1
2020
375
0.120
 Why?
Cholangitis, Sclerosing
1
2016
60
0.120
 Why?
Radiographic Image Enhancement
1
2016
57
0.120
 Why?
Cannabis
1
2023
509
0.120
 Why?
Sex Factors
1
2022
2112
0.120
 Why?
Bacteriocins
1
2015
4
0.110
 Why?
Printing, Three-Dimensional
1
2016
96
0.110
 Why?
Embolization, Therapeutic
1
2018
242
0.110
 Why?
Hepatitis B
1
2016
66
0.110
 Why?
Genes, BRCA2
1
2015
33
0.110
 Why?
Genes, BRCA1
1
2015
45
0.110
 Why?
Pneumonia, Viral
1
2020
384
0.110
 Why?
Recovery of Function
1
2019
707
0.110
 Why?
Interferon-gamma
1
2018
784
0.110
 Why?
Coronavirus Infections
1
2020
378
0.110
 Why?
Papilloma, Intraductal
1
2014
1
0.110
 Why?
Heredity
1
2014
12
0.110
 Why?
Organ Preservation
3
2004
130
0.110
 Why?
Machine Learning
1
2020
585
0.110
 Why?
Diabetes Mellitus, Type 1
10
2010
3890
0.110
 Why?
Membrane Proteins
1
2021
1166
0.110
 Why?
Apoptosis
6
2021
2430
0.100
 Why?
Germany
2
2024
138
0.100
 Why?
Genomics
2
2017
834
0.100
 Why?
Risk Adjustment
1
2014
85
0.100
 Why?
Amylases
1
2013
18
0.100
 Why?
Neoplasm, Residual
1
2014
139
0.100
 Why?
Tissue and Organ Harvesting
5
2005
73
0.100
 Why?
High-Throughput Nucleotide Sequencing
1
2017
549
0.100
 Why?
MicroRNAs
2
2010
701
0.100
 Why?
Virus Diseases
1
2016
216
0.100
 Why?
Health Care Surveys
2
2025
539
0.100
 Why?
Tacrolimus
2
2005
196
0.100
 Why?
Reproducibility of Results
6
2019
3409
0.100
 Why?
North America
2
2024
310
0.100
 Why?
Severity of Illness Index
3
2019
2925
0.100
 Why?
Cell Proliferation
5
2021
2496
0.100
 Why?
Perception
1
2016
377
0.100
 Why?
Antibodies, Monoclonal
4
2005
1519
0.100
 Why?
Syndrome
1
2014
380
0.100
 Why?
Abdomen
2
2004
141
0.100
 Why?
Precision Medicine
1
2017
457
0.100
 Why?
Cadaver
8
2005
304
0.100
 Why?
Diagnostic Imaging
1
2015
338
0.090
 Why?
Breast Neoplasms
2
2024
2452
0.090
 Why?
Diagnostic Errors
1
2014
175
0.090
 Why?
Imaging, Three-Dimensional
1
2016
583
0.090
 Why?
Insulin-Secreting Cells
2
2007
388
0.090
 Why?
ROC Curve
3
2024
614
0.090
 Why?
Immunotherapy, Adoptive
1
2016
337
0.090
 Why?
Receptors, Antigen, T-Cell
1
2016
668
0.090
 Why?
Endoscopy
1
2014
316
0.090
 Why?
Child
6
2026
22633
0.090
 Why?
Catheter Ablation
1
2015
353
0.090
 Why?
C-Reactive Protein
1
2013
416
0.090
 Why?
Neoplasms
2
2022
2875
0.090
 Why?
Loss of Heterozygosity
1
2011
52
0.080
 Why?
Carcinoma in Situ
1
2011
44
0.080
 Why?
Graft Rejection
5
2005
540
0.080
 Why?
Biomarkers
1
2022
4271
0.080
 Why?
Kruppel-Like Transcription Factors
1
2011
78
0.080
 Why?
Raffinose
3
2005
29
0.080
 Why?
Disaccharides
3
2005
21
0.080
 Why?
Mannitol
3
2005
40
0.080
 Why?
Glucose
3
2020
1047
0.080
 Why?
Allopurinol
3
2005
69
0.080
 Why?
Histidine
3
2005
66
0.080
 Why?
Glutamates
3
2005
66
0.080
 Why?
Electrolytes
3
2005
55
0.080
 Why?
Tissue and Organ Procurement
2
2004
346
0.080
 Why?
Lung Neoplasms
1
2023
2637
0.080
 Why?
CD8-Positive T-Lymphocytes
1
2016
917
0.080
 Why?
Duodenum
1
2010
77
0.080
 Why?
Lymph Nodes
2
2024
502
0.070
 Why?
Quality of Health Care
1
2014
691
0.070
 Why?
Peptides
1
2015
995
0.070
 Why?
Tumor Cells, Cultured
2
2021
919
0.070
 Why?
Cell Line, Tumor
4
2025
3540
0.070
 Why?
Down-Regulation
1
2011
627
0.070
 Why?
Intra-Abdominal Fat
1
2009
100
0.070
 Why?
T-Lymphocytes, Regulatory
2
2022
389
0.070
 Why?
Adenosine
3
2005
255
0.070
 Why?
Glutathione
3
2005
375
0.070
 Why?
Magnetic Resonance Angiography
1
2010
251
0.070
 Why?
Enzyme Replacement Therapy
2
2018
15
0.070
 Why?
Feasibility Studies
2
2026
1095
0.070
 Why?
Germ-Line Mutation
2
2019
172
0.070
 Why?
Morbidity
2
2019
323
0.070
 Why?
ErbB Receptors
1
2010
627
0.070
 Why?
Gliclazide
1
2007
2
0.060
 Why?
Consensus
2
2020
488
0.060
 Why?
Diabetic Retinopathy
2
2006
208
0.060
 Why?
Cytotoxicity, Immunologic
2
2018
223
0.060
 Why?
Equilibrative Nucleoside Transporter 1
1
2006
20
0.060
 Why?
Arterial Occlusive Diseases
1
2007
90
0.060
 Why?
Clinical Decision-Making
2
2020
359
0.060
 Why?
Extracorporeal Circulation
1
2006
15
0.060
 Why?
Blood Loss, Surgical
1
2007
112
0.060
 Why?
Pancreatic Pseudocyst
1
2025
18
0.060
 Why?
Hepatic Veins
1
2006
32
0.060
 Why?
C-Peptide
1
2007
189
0.060
 Why?
Lacerations
1
2006
40
0.060
 Why?
Hepatectomy
2
2024
273
0.060
 Why?
Neovascularization, Pathologic
1
2007
286
0.060
 Why?
Tumor Microenvironment
2
2020
732
0.060
 Why?
Vena Cava, Inferior
1
2006
81
0.060
 Why?
Smartphone
1
2026
102
0.060
 Why?
Alcohol Drinking
2
2013
826
0.050
 Why?
Smoking
2
2013
1472
0.050
 Why?
Transplantation, Autologous
1
2006
290
0.050
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
29
0.050
 Why?
Abdominal Injuries
1
2006
127
0.050
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
240
0.050
 Why?
Drug Resistance, Neoplasm
1
2010
881
0.050
 Why?
Jehovah's Witnesses
1
2004
3
0.050
 Why?
Bezoars
1
2004
5
0.050
 Why?
Succinimides
1
2024
21
0.050
 Why?
Biopsy
3
2019
1075
0.050
 Why?
Contrast Media
3
2016
488
0.050
 Why?
Anthropometry
1
2024
200
0.050
 Why?
Splenectomy
1
2024
65
0.050
 Why?
Chemotaxis
1
2004
122
0.050
 Why?
Intestinal Obstruction
1
2004
56
0.050
 Why?
Cystectomy
1
2003
41
0.050
 Why?
RNA, Messenger
5
2011
2832
0.050
 Why?
Mobile Applications
1
2026
196
0.050
 Why?
Antioxidants
1
2007
549
0.050
 Why?
Intestine, Small
1
2004
166
0.050
 Why?
Postoperative Period
2
2019
354
0.050
 Why?
Ileum
1
2003
111
0.050
 Why?
Intraoperative Complications
1
2004
155
0.050
 Why?
Wounds, Nonpenetrating
1
2006
316
0.050
 Why?
Academic Medical Centers
1
2025
547
0.050
 Why?
Propylamines
1
2022
11
0.050
 Why?
Delphi Technique
1
2024
329
0.040
 Why?
Carbohydrates
1
2022
66
0.040
 Why?
Genetic Testing
1
2005
478
0.040
 Why?
Patient Reported Outcome Measures
1
2026
488
0.040
 Why?
Patient Satisfaction
1
2026
704
0.040
 Why?
Azathioprine
1
2001
49
0.040
 Why?
Program Evaluation
1
2026
948
0.040
 Why?
Gastrectomy
1
2023
161
0.040
 Why?
Stents
2
2022
556
0.040
 Why?
Creatinine
4
2004
506
0.040
 Why?
Urinary Bladder
1
2003
194
0.040
 Why?
Vascular Diseases
1
2004
251
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
983
0.040
 Why?
Guideline Adherence
1
2025
589
0.040
 Why?
Mycophenolic Acid
1
2001
120
0.040
 Why?
Necrosis
1
2022
244
0.040
 Why?
Retroperitoneal Space
3
2005
18
0.040
 Why?
Steroids
1
2001
160
0.040
 Why?
Ephrin-B2
1
2021
45
0.040
 Why?
Hernia, Inguinal
1
2001
43
0.040
 Why?
Endometriosis
1
2001
57
0.040
 Why?
Hyperplasia
1
2021
174
0.040
 Why?
Endoscopy, Gastrointestinal
1
2023
237
0.040
 Why?
Urinary Bladder Neoplasms
1
2003
255
0.040
 Why?
Microbial Viability
1
2021
90
0.040
 Why?
Case-Control Studies
2
2022
3604
0.040
 Why?
Diagnosis, Computer-Assisted
1
2020
91
0.040
 Why?
Capecitabine
1
2019
57
0.040
 Why?
Adipose Tissue
1
2024
652
0.040
 Why?
Secretin
2
2010
6
0.040
 Why?
Matched-Pair Analysis
1
2019
37
0.040
 Why?
Republic of Korea
1
2019
42
0.040
 Why?
Florida
1
2020
117
0.040
 Why?
Medical Oncology
1
2022
332
0.040
 Why?
Mice, Inbred C57BL
2
2021
5992
0.040
 Why?
Asia
1
2019
70
0.040
 Why?
Treatment Failure
3
2005
365
0.040
 Why?
Patient Discharge
1
2026
983
0.040
 Why?
Mice
3
2022
18339
0.040
 Why?
Hematopoietic Stem Cell Transplantation
1
2005
675
0.040
 Why?
International Cooperation
1
2020
198
0.040
 Why?
Cell Death
1
2021
383
0.040
 Why?
Area Under Curve
1
2019
330
0.040
 Why?
Cells, Cultured
3
2016
4154
0.040
 Why?
Aquaporin 1
1
2018
3
0.040
 Why?
Hyperthermia, Induced
1
2020
121
0.040
 Why?
Acute Disease
1
2022
1030
0.040
 Why?
Mice, Nude
1
2020
682
0.040
 Why?
Radiotherapy
1
2019
206
0.040
 Why?
Pancreatic Elastase
1
2018
55
0.040
 Why?
Stromal Cells
1
2019
124
0.030
 Why?
Congresses as Topic
1
2020
221
0.030
 Why?
Cause of Death
3
2005
471
0.030
 Why?
Anastomosis, Roux-en-Y
2
2010
26
0.030
 Why?
Multivariate Analysis
2
2013
1539
0.030
 Why?
Hospitals, High-Volume
1
2018
49
0.030
 Why?
Xenograft Model Antitumor Assays
1
2021
928
0.030
 Why?
Preoperative Period
1
2018
149
0.030
 Why?
Tumor Suppressor Protein p53
2
2017
529
0.030
 Why?
Betacoronavirus
1
2020
286
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2010
758
0.030
 Why?
Patient Safety
1
2020
347
0.030
 Why?
Intestinal Neoplasms
1
2016
30
0.030
 Why?
Registries
1
2025
2385
0.030
 Why?
Diabetic Nephropathies
3
2005
318
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2017
253
0.030
 Why?
Cell Movement
1
2021
965
0.030
 Why?
Drug Therapy, Combination
3
2004
1047
0.030
 Why?
Principal Component Analysis
1
2016
197
0.030
 Why?
Robotic Surgical Procedures
1
2019
182
0.030
 Why?
Mass Spectrometry
1
2019
750
0.030
 Why?
Transplantation, Homologous
2
2010
415
0.030
 Why?
Nutritional Status
1
2018
354
0.030
 Why?
Vitamins
1
2017
178
0.030
 Why?
Anastomosis, Surgical
1
2016
157
0.030
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
121
0.030
 Why?
Research Design
1
2021
1135
0.030
 Why?
Cell Line
1
2021
2882
0.030
 Why?
Feces
1
2018
513
0.030
 Why?
Anatomy, Cross-Sectional
1
2014
11
0.030
 Why?
Flow Cytometry
1
2018
1173
0.030
 Why?
Extracellular Matrix
1
2019
553
0.030
 Why?
Radiation Dosage
1
2016
192
0.030
 Why?
Animals
3
2022
38058
0.030
 Why?
Intraoperative Care
1
2014
62
0.030
 Why?
Antigens, Neoplasm
1
2016
271
0.030
 Why?
Systemic Inflammatory Response Syndrome
1
2014
96
0.030
 Why?
Kidney Failure, Chronic
3
2004
598
0.030
 Why?
Immunologic Memory
1
2016
366
0.020
 Why?
Dose-Response Relationship, Drug
2
2010
2027
0.020
 Why?
Indole Alkaloids
1
2013
7
0.020
 Why?
Drug Administration Schedule
2
2005
779
0.020
 Why?
Cytokines
2
2016
2061
0.020
 Why?
Drug Interactions
2
2005
398
0.020
 Why?
Peptic Ulcer
1
2013
18
0.020
 Why?
Biomedical Research
1
2019
710
0.020
 Why?
Histocompatibility Testing
2
2004
121
0.020
 Why?
Pregnancy
1
2026
7190
0.020
 Why?
Algorithms
1
2020
1837
0.020
 Why?
Asymptomatic Diseases
1
2013
102
0.020
 Why?
Safety
2
2004
356
0.020
 Why?
Lymphocyte Activation
1
2016
1126
0.020
 Why?
Global Health
1
2015
401
0.020
 Why?
Pandemics
1
2020
1694
0.020
 Why?
Hypoxia
1
2019
1199
0.020
 Why?
Infant
1
2025
10034
0.020
 Why?
Carcinoma, Renal Cell
1
2013
234
0.020
 Why?
In Situ Hybridization
1
2011
319
0.020
 Why?
Korea
1
2010
18
0.020
 Why?
Cell Growth Processes
1
2010
50
0.020
 Why?
Randomized Controlled Trials as Topic
1
2017
1720
0.020
 Why?
Microsatellite Repeats
1
2011
157
0.020
 Why?
Matrix Metalloproteinase 2
1
2010
56
0.020
 Why?
Odds Ratio
1
2013
1075
0.020
 Why?
Biopsy, Needle
1
2010
183
0.020
 Why?
Anti-Bacterial Agents
1
2021
1907
0.020
 Why?
Lung
1
2023
4109
0.020
 Why?
Matrix Metalloproteinase 9
1
2010
132
0.020
 Why?
Cardiovascular Diseases
1
2001
2168
0.020
 Why?
Edetic Acid
1
2009
47
0.020
 Why?
Pyridoxal Phosphate
1
2009
25
0.020
 Why?
Thyroid Neoplasms
1
2013
345
0.020
 Why?
PTEN Phosphohydrolase
1
2010
164
0.020
 Why?
Blood Glucose
3
2004
2327
0.020
 Why?
Kidney Neoplasms
1
2013
412
0.020
 Why?
Tetrazolium Salts
1
2008
18
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2010
436
0.020
 Why?
Thiazoles
1
2008
135
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2010
557
0.020
 Why?
Glyburide
1
2007
31
0.020
 Why?
bcl-2-Associated X Protein
1
2007
54
0.020
 Why?
Surgical Procedures, Operative
1
2010
270
0.020
 Why?
Recurrence
1
2010
1135
0.020
 Why?
Deoxycytidine Kinase
1
2006
3
0.020
 Why?
Epigenesis, Genetic
1
2011
684
0.020
 Why?
Microscopy, Electron
1
2007
415
0.020
 Why?
Ribonucleoside Diphosphate Reductase
1
2006
6
0.020
 Why?
Choledochostomy
1
2006
10
0.010
 Why?
Motorcycles
1
2006
7
0.010
 Why?
Tyrosine
1
2007
222
0.010
 Why?
Budd-Chiari Syndrome
1
2006
5
0.010
 Why?
Mutation
1
2017
4089
0.010
 Why?
5'-Nucleotidase
1
2006
49
0.010
 Why?
Cytidine Deaminase
1
2006
59
0.010
 Why?
Prostatic Neoplasms
1
2013
974
0.010
 Why?
Phosphorylation
1
2010
1732
0.010
 Why?
Economics, Pharmaceutical
1
2005
10
0.010
 Why?
Antilymphocyte Serum
1
2005
61
0.010
 Why?
Fluorescein Angiography
1
2006
189
0.010
 Why?
Methylprednisolone
1
2005
64
0.010
 Why?
Fatal Outcome
1
2006
307
0.010
 Why?
Blood Group Incompatibility
1
2005
20
0.010
 Why?
Colorectal Neoplasms
1
2013
845
0.010
 Why?
Maximum Tolerated Dose
1
2005
212
0.010
 Why?
Isoantibodies
1
2005
57
0.010
 Why?
Hemorrhage
1
2010
809
0.010
 Why?
Glycerolphosphate Dehydrogenase
1
2004
5
0.010
 Why?
Accidents, Traffic
1
2006
190
0.010
 Why?
Fructose-Bisphosphate Aldolase
1
2004
10
0.010
 Why?
Proteomics
1
2011
1195
0.010
 Why?
Glucokinase
1
2004
15
0.010
 Why?
DNA Primers
1
2005
512
0.010
 Why?
Pyruvate Kinase
1
2004
28
0.010
 Why?
Intraocular Pressure
1
2006
328
0.010
 Why?
Tissue Culture Techniques
1
2004
83
0.010
 Why?
Pharmacogenetics
1
2005
172
0.010
 Why?
Transcriptional Activation
1
2006
383
0.010
 Why?
Diabetic Neuropathies
1
2005
99
0.010
 Why?
Renal Circulation
1
2004
75
0.010
 Why?
Tumor Suppressor Proteins
1
2006
321
0.010
 Why?
Visual Acuity
1
2006
489
0.010
 Why?
Kidney Function Tests
1
2003
157
0.010
 Why?
Carcinoma, Transitional Cell
1
2003
68
0.010
 Why?
Monitoring, Physiologic
1
2005
289
0.010
 Why?
Cell Separation
1
2004
307
0.010
 Why?
In Vitro Techniques
1
2004
1047
0.010
 Why?
Respiratory Insufficiency
1
2006
326
0.010
 Why?
Base Sequence
1
2005
2190
0.010
 Why?
Vulvar Diseases
1
2001
9
0.010
 Why?
Thrombosis
1
2005
393
0.010
 Why?
Obesity, Morbid
1
2005
281
0.010
 Why?
Immunoenzyme Techniques
1
2001
200
0.010
 Why?
Gene Expression
1
2006
1490
0.010
 Why?
Glucocorticoids
1
2005
535
0.010
 Why?
Ischemia
1
2004
421
0.010
 Why?
Morphogenesis
1
2001
173
0.010
 Why?
Hemodynamics
1
2004
1121
0.010
 Why?
Neoplasm Proteins
1
2001
442
0.010
 Why?
Blood Pressure
1
2005
1769
0.010
 Why?
T-Lymphocytes
1
2005
1982
0.010
 Why?
Body Mass Index
1
2004
2438
0.010
 Why?
Hypoglycemic Agents
1
2005
1387
0.010
 Why?
Infant, Newborn
1
2001
6429
0.000
 Why?
Del Chiaro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (599) concept(s)
_
Co-Authors Expand Description
See all (59) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)